Evidence map›Paper›PMID 25059483›Full record

ArticleJournal of autism and developmental disorders2015

Genetic variation in melatonin pathway enzymes in children with autism spectrum disorder and comorbid sleep onset delay.

Olivia J Veatch, Julie S Pendergast, Melissa J Allen, Roberta M Leu, Carl Hirschie Johnson, Sarah H Elsea, Beth A Malow

Open access · greenAbstract read
In one paragraph

Article in Journal of autism and developmental disorders, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed, 2 pooled it
1.7field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 2 syntheses or guidelines pooled it, 85 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. Review
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Olivia J VeatchSleep Disorders Division, Department of Neurology, Vanderbilt University Medical Center, 1161 21st Ave. S., Nashville, TN, 37232, USA, olivia.j.veatch@vanderbilt.edu.
Julie S Pendergast
Melissa J Allen
Roberta M Leu
Carl Hirschie Johnson
Sarah H Elsea
Beth A Malow
Vanderbilt University Medical Center · USBaylor College of Medicine · USEmory University · US

Funding

VANDERBILT UNIVERSITY CTSA FOR PEDIATRIC RESEARCHUL1RR024975 · NCRR · VANDERBILT UNIVERSITY · PI BERNARD, GORDON RAPHAEL · 2007 to 2011
$45.7M
The Vanderbilt Institute for Clinical and Translational Research (VICTR)UL1TR000445 · NCATS · VANDERBILT UNIVERSITY MEDICAL CENTER · PI BERNARD, GORDON RAPHAEL · 2012 to 2016
$41.4M
TRAINING PROGRAM/RESPIRATORY NEUROBIOLOGY AND SLEEPT32HL007713 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI PACK, ALLAN I · 1992 to 2022
$11.9M
Research Project: Sensory and Multisensory Contributions to AutismU54HD083211 · NICHD · VANDERBILT UNIVERSITY MEDICAL CENTER · PI DYKENS, ELISABETH MAY · 2015 to 2019
$7.1M
Circadian Programs in BacteriaR37GM067152 · NIGMS · VANDERBILT UNIVERSITY · PI JOHNSON, CARL HIRSCHIE · 2015 to 2024
$4.1M
Melatonin for Sleep in Children with Autism: Safety, Tolerability, and DosingR01HD059253 · NICHD · VANDERBILT UNIVERSITY · PI MALOW, BETH A · 2008 to 2009
$873k
Circadian Clock Gene Polymorphisms Associated with DepressionR21MH082258 · NIMH · VANDERBILT UNIVERSITY · PI JOHNSON, CARL HIRSCHIE · 2009 to 2010
$426k
NCATS NIH HHS UL1 TR000445NCRR NIH HHS RR024975NCRR NIH HHS UL1 RR024975NHLBI NIH HHS T32 HL007713NICHD NIH HHS 1R01HD059253NICHD NIH HHS R01 HD059253NICHD NIH HHS U54 HD083211NIGMS NIH HHS R37 GM067152NIMH NIH HHS 1R21MH082258-01A2NIMH NIH HHS R21 MH082258
6 · The paper itself

Abstract

Sleep disruption is common in individuals with autism spectrum disorder (ASD). Genes whose products regulate endogenous melatonin modify sleep patterns and have been implicated in ASD. Genetic factors likely contribute to comorbid expression of sleep disorders in ASD. We studied a clinically unique ASD subgroup, consisting solely of children with comorbid expression of sleep onset delay. We evaluated variation in two melatonin pathway genes, acetylserotonin O-methyltransferase (ASMT) and cytochrome P450 1A2 (CYP1A2). We observed higher frequencies than currently reported (p < 0.04) for variants evidenced to decrease ASMT expression and related to decreased CYP1A2 enzyme activity (p ≤ 0.0007). We detected a relationship between genotypes in ASMT and CYP1A2 (r(2) = 0.63). Our results indicate that expression of sleep onset delay relates to melatonin pathway genes.

Indexed as

Acetylserotonin O-MethyltransferaseChildChild Development Disorders, PervasiveChild, PreschoolClinical Trials as TopicCytochrome P-450 CYP1A2DNA Mutational AnalysisEndophenotypesGenotypeHumansMaleMelatoninMutationPolymorphism, Single NucleotideSleep Initiation and Maintenance DisordersAcetylserotonin O-MethyltransferaseCYP1A2 protein, humanCytochrome P-450 CYP1A2Melatonin

Identifiers

PMID25059483
PMCPMC4289108
OpenAlexW2026710595

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.